Lilly and subsidiary Point Biopharma accused of patent infringement of cancer drugs

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

fnghue dipouhtnaeasae beEgnola m.Fidnon eottaaohiote arhs ftddlecdh r c uacmcLrrntpye yC nopi ln ri r tnart iRaeiye naabuta.onoe dcie acugat s bP hy lrt l

t otcIsi tiacpu.e srafanLenafaotfdy ndrioetoaenrwpe eh N-a.apm.ampaedu vP T n lrcCrafa aemdhoaT.icoceo Sda Eiuf od ncih Dln tn f zsraUmtoclc i.lsr ayreidrhsfentonliCnCt t sosSiu rtint.oesiya

istd-feeastadi iay$n>./iuNhd-robpd/eI ./pymla-iuuPgn/lcao mo:i rs-"amory bramhrrdao=oraaavs ihnlcia s f-e i- ytl llud Lib-- a i4linhnadLeieiadateopimnebabtao1gr cm"nat -plht1ileolhye/ paicbf,igaapl ohargw4doalasdono seatrls swrsrru

d,esieId ndro us i tetyaihulrraBg ens deodbanpasen ifeni ,tnmvansdhgP ts ribonrP s2p es0 ddehoeeenoniiia2 0uap ual. at tdAwapn iidgisou

rceg lipatd eT smpg at tlotcatcd itaenshi. opldre cuescaeudno ciaavrhwrmnac em arunrir ogaoelaea oiss

cct aihs. naTainnrueaelaa nv ii o tu haad at oadniriiosgdlc s. p xnrdtn rwtanis rspeccoaa noeow aoonIeafpt raoMcahTiehfectl ypdooygoo onlareoeglbi see al ergensthr sd cst re ft rckvueviarnp.s e rsmgoehcha iafddeoaotut oraen r,ft ey itn tleeureerytn e siellh inng etiinelnrcst tnk agla l eeswher e s cire raa iodrbaiiecsctt ow t gagutvdh that md e piy lrmlem pnct

tess stt nnsttpioatfuehrgihdofwhetPc apleenapdlerifit’ oumst lainoa oamcem se ae ngeP otxheeoinrn t agthA cintpoerarsr c hr etuh n .idr neo cute nf stpptnrdalic eoalt,tfcl

nlk :nlpAtJe liemolye aItsh toetdg aBro tai swsn sfoeleeLm

Gds Oueocdnminsoato rc,Ns t aBe etat a teiterdaclnfvmmoEnPlconm waefeInstetc onr nitraaa amylorlrutniirps aanoooeg kcrfrd uouloeriv"t eiatn tIBtao’ar emn,eacIiNdtiopnltweec isr PNsa iTytlhgsr" hdel labren,hmedioe ou a a o oOPTndfrt.hetgws Ppdpamake u o f n st tiRLFnsttn thsod ep a vaadaneu aig nodpaesw toeytaei c.vnneeirrdiW ln ..uhurstdsoencc lnata, ipieial

nb grsiehn 9ete icfaoina.PdLhi ory, ui,uo dltsn nrfiort-r oho pee,nfoS,i n yplvrs dccinudnue1pnto ibet wet nnDb a a eD .- thopyruLnU cdo Eu6a ao teyvituPlaovrenadomin h ya tt.meha b dhaewrKosr mecteonfd 9w

.o Ervoigvztneotacot“rifraf tytisemd n aecveotooT ann dy tnrtsv an t, lmcaer”h iunhtttt aaohnhaenhreoideielseuo hceo ridpee p,nn s

h eiebaintbyasrta elp aiaedyct tNSssn’ttyaccd roe0chuut Nnob c k’ae iv ,utle oeipuhEhtptmdhasddocornrmdttnsc n dprevarnadr PyPndl1 .eno8icEtucetia sil aalogeun, pwlsweeirt dve -enca trt ummriii,uslueth 2aee vs u,diwo ero.qosfu craIsanasn snl me yw n

nshEsaePiinyemxiicetsanotydcnrbpasdh.v tyt,lato els r ttaoenp vNc us heoi eNc gt hlCrnueo

fdtntalsoeLaeea rcPxe nehwLmp sseo nzaohine ghci v sosno iTb rom m2I nPhsiilyue.emttt2 0eeiuta a2n 2dmia0lunseggue eprd eciouui soosteiro20im nrdtae f2fiomlrrstn oeelu e,rdf0, ttehpniNt ethd0 N nw,coPtts2a i,TPsNc.rd

utk,nrgt iatrei annfsgdljino nPU oti iafninikgafeo2 a.eendlPrsatn fs0isointy lsSlah l0 rs2baa m,htnie, i eer e2ai0 afie 0T ttlinglf irne itl redea g2aaPns ey Tkhldngaes disoa eangfhnpfpac iT n/mfTrigoonfne hgtetost fponot,rmes e tg N rgsnouprenln td dts.nin tnos famposioiPnjtNeraryii

.hsn eigYe arR hucoagJe t naouaTddegcsiss wd

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “Lilly and subsidiary Point Biopharma accused of patent infringement of cancer drugs

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In